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Abstract
Background: In West Africa, the carriage of Group B Streptococcus (GBS), among infants is poorly characterised.
We investigated co-carriage of GBS with other respiratory pathogens in the infants’ nasopharynx in The Gambia.
Methods: We assessed the carriage, serotypes and antibiotic susceptibility of Beta-haemolytic Streptococci (BHS)
groups A-G; along with the carriage of Streptococcus pneumoniae; Haemophilus influenzae; Staphylococcus aureus
and Moraxella catarrhalis in 1200 two-month old infants.
Results: The BHS prevalence was 20.0 % and GBS dominated (13.8 %), particularly serotypes V and II; serotype V
being negatively associated with H. Influenzae carriage (OR 0.41 [95 % CI: 0.18–0.93], p = 0.033). Although co-colonization
of GBS and other BHS was not seen, colonization with GBS was positively associated with S. aureus (OR 1.89 [95 % CI: 1.
33–2.69], P < 0.001) and negatively associated with S. pneumoniae (OR 0.47 [95 % CI: 0.33–0.67], p < 0.001) and M.
catarrhalis (OR 0.61 [95 % CI: 0.40–0.92], p = 0.017). ≥ 89 % of GBS isolates were susceptible to most antibiotics
tested, except for tetracycline resistance, which was 89 %.
Conclusion: This study provides baseline data on the carriage of GBS in two month old infants from West Africa.
The dominant serotypes of GBS in this setting are serotypes V and II. This may be important for future GBS vaccine
development for the West African sub-region.
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Background
The beta-haemolytic group of Streptococci (BHS) causes a
wide variety of infections ranging from mild skin infec-
tions to life threatening diseases including sepsis and men-
ingitis [1, 2]. BHS are classified into Lancefield serogroups
(A –G) depending on their cell wall structure [3]. BHS are
amongst the top ten causes of invasive bacterial diseases
in adults and children beyond the neonatal period [4, 5].
A sub-group of the BHS is Group B Streptococcus
(GBS) also known as Streptococcus agalactiae, which is a
major cause of neonatal sepsis and meningitis with sig-
nificant morbidity and mortality rates in the developed
world [6, 7]. However, there are historical and now
emerging data suggesting that GBS may also be a fre-
quent cause of neonatal sepsis in sub-Saharan Africa [8–
10]. GBS comprises ten serotypes (Ia, Ib, II-IX) and
there are geographical variations with respect to the pre-
dominant serotypes in invasive disease [7, 11, 12].
Microbes colonizing the nasopharynx can invade the
blood stream or migrate to contiguous surfaces of the
respiratory tract [13]. Consequently, nasopharyngeal car-
riage of respiratory pathogens such as S. pneumoniae is
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a risk factor for the development of several infections in-
cluding pneumonia, meningitis and sepsis [14]. Droplet
secretions from the nasopharynx are also an important
mechanism for the horizontal transfer of pathogens [15].
The epidemiology, transmission and nasopharyngeal car-
riage of S. pneumoniae and Haemophilus influenzae type
b (Hib) have been studied in the Gambia [16, 17]. How-
ever, nasopharyngeal co-carriage of GBS with other re-
spiratory pathogens in the post pneumococcal and Hib
conjugate vaccine era has not been described in West
Africa.
This study investigated co-carriage of GBS with other
BHS and four common respiratory pathogens colonizing
the nasopharyngeal mucosae beyond the first week of
life. We also characterised the carriage, serotypes and
antibiotic susceptibility of GBS in these Gambian infants
who had not yet been vaccinated with the pneumococcal
conjugate and Hib vaccines. This study provides critical
baseline data on the carriage of GBS and other BHS in
the sub-region.
Methods
Study area and population
The study was conducted in the Fajikunda district, a typ-
ical peri-urban setting in the Western region of The
Gambia. As described previously, this area is representa-
tive of similar communities situated near large cities in
West Africa [18].
Nasopharyngeal swabs (NPS) were obtained between
July 2011 and May 2012 from 1200 healthy infants aged
two months of consenting parents at the Fajikunda in-
fants’ well-being clinic.
The Gambia Government/MRC Joint Ethics Commit-
tee approved the study. Trained field workers/nurses ex-
plained the contents of the study information sheet to
parents/guardians in their own language. Parents/guard-
ians of all study participants gave written informed con-
sent prior to enrolment.
The study team administered questionnaires to record
history of acute respiratory tract infection, place of birth
(whether in a health facility or at home), cooking
method, ethnic group, number of other infants less than
5 years in the household and sex.
Nasopharyngeal swab sampling methods
NPS were collected as described previously [18] and
were processed for the isolation of BHS and four add-
itional respiratory pathogens including S. pneumoniae,
H. influenzae, S. aureus and M. catarrhalis.
Microbiological methods
Identification and isolation of bacterial pathogens
The broth enrichment method for enhancing the yield
of S. pneumoniae [19] was adapted to improve the yield
of BHS and other respiratory pathogens. Briefly, NPS
stored in Skim-milk Tryptone Glucose Glycerol were
thawed at room temperature (25 °C) and briefly vor-
texed. 200 μl of the NPS in Skim-milk Tryptone Glucose
Glycerol was inoculated into 5mls of Todd-Hewitt Broth
with 5 % Yeast Extract (Oxoid, Basingstoke, UK) contain-
ing 1 ml of rabbit serum (B&K Universal Ltd, Grimston,
East Yorkshire, UK) and incubated for 5-6 h at 37 °C in
ambient air.
For BHS isolation, 100 μl aliquots were streaked onto
a 5 % Sheep Blood Agar plate containing a 1:50000 dilu-
tion of crystal violet to inhibit Staphylococcus growth.
For M. catarrhalis, H. influenzae, S. pneumoniae and S.
aureus isolation, aliquots of 100 μl were streaked onto
each of Chocolate agar, Bacitracin chocolate agar, Genta-
micin sheep blood agar and Mannitol salt agar plates, re-
spectively. All plates were incubated overnight at 37 °C;
Gentamicin sheep blood agar, Bacitracin chocolate agar
and Chocolate agar plates in 5 % CO2; Crystal violet
blood agar and Mannitol Salt agar in ambient air.
Isolation and identification of bacterial pathogens (H.
influenzae, S. pneumoniae, M. catarrhalis and S. aureus)
were carried out as previously reported [18]. For H.
influenzae; type B specific antisera obtained from Statens
Serum Institut (SSI, Copenhagen, Denmark) was used to
serotype the isolates as Hib or non-Hib.
Isolation of BHS was carried out as follows. Following
overnight incubation of the Crystal violet blood agar
plates, 2-3 colourless or grey, dry or moist, beta-
haemolytic colonies were individually streaked to Blood
agar plates. A 0.04 Units bacitracin disk (BD Oxoid,
Basingstoke, UK) was placed in the first quadrant for the
preliminary identification of Group A Streptococcus
(GAS). The plates were then incubated overnight at 37 °
C in 5 % CO2. All bacitracin negative, catalase negative
colonies were subjected to the Christie, Atkins, Munch
and Peterson test for the preliminary identification of
GBS. S. agalactiae (ATCC 12386) were inoculated as
negative and positive controls, respectively, for each
batch of testing. All beta-haemolytic isolates (including
all isolates preliminarily identified as GAS and GBS)
were further grouped using the Streptex® Streptococcal
grouping kit (Remel & Oxoid, Thermo Fisher Scientific,
Basingstoke, UK) for confirmation as GAS, GBS, Group
C (GCS) or group G (GGS). All isolates were stored in
15 % Glycerol broth at −70 °C until further testing.
Serotyping of GBS isolates
Latex agglutination method
One hundred thirty-three out of 162 (82 %) GBS isolates
were successfully revived for serotyping by the slide latex
agglutination method. Confirmed GBS isolates were
streaked onto a 5 % Blood agar plate to obtain fresh cul-
tures. Serotyping was carried out using Strep-B-latex
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antisera® (SSI, Copenhagen, Denmark) as per manufac-
turer’s instructions. For each batch of serotyping, serotype
specific GBS controls strains Ia, Ib, II – IX obtained from
Centres for Disease Control and Prevention, Atlanta
(Strain numbers 2008232728, 2008232729, 2008232738,
2008232582, 2011201884, 2008232731, 2010228816,
4832–06, 5030–08, 7509–07 respectively) [20] were used
as positive controls.
Conventional PCR serotyping method
All the GBS strains which were non-typeable (NT) by
the latex agglutination method (21/133, 15.8 %) were
subjected to the conventional serotyping method (Poly-
merase Chain Reaction, PCR). In addition, 15.0 % of all
the GBS strains typed by the latex agglutination method
(20/133) were confirmed by PCR.
DNA was extracted from pure overnight colonies of
GBS following as per the World Health Organization
(WHO) Laboratory manual for the diagnosis of men-
ingitis [21].
Serotyping was then carried out using the method of
Imperi et al. [20]. For each run, non-template negative
controls as well as positive GBS control strains (sero-
types Ia, Ib, II-IX (Centres for Disease Control and Pre-
vention, Atlanta, USA) were included.
Susceptibility testing
All the 133 GBS isolates that were serotyped were fur-
ther tested for their susceptibility to Penicillin (10 units),
Chloramphenicol (30 μg), Tetracycline (30 μg) and
Erythromycin (15 μg) discs (BD Oxoid, Basingstoke,
United Kingdom) by the Kirby-Bauer method. E-tests
(Biomerieux, Basingstoke, United Kingdom Limited)
were performed for all isolates showing resistant or
intermediate sensitivities by the Kirby-Bauer method.
All interpretation of antibiotic susceptibilities were
done using CLSI breakpoints [22].
All reagents and the disc dispenser were obtained from
BD Oxoid, Basingstoke, UK, except otherwise stated.
The MRC Unit The Gambia, molecular microbiology
laboratory submits to the external quality assurance
programme of the UK National External Quality Assess-
ment Service [23] and is a World Health Organization
(WHO) Regional Reference Laboratory for invasive bac-
terial pathogens.
Statistical analysis
Data management was done using SQL integrated data-
base with a Microsoft Access front-end linked to field,
clinical and laboratory databases.
All statistical analyses were conducted in Stata version
12 for Windows (Stata Corp, College Station, TX). Any
association with a p value of <0.05 was considered to be
significant.
Categorical variables were summarised using frequency
counts and percentages, n (%). Mean (SD) and median
(IQR) values were used to describe normally and non-
normally distributed continuous variables, respectively.
Cross tabulations (with Fishers’ exact tests for associa-
tions) were used to describe and compare the prevalence
of BHS carriage across different levels of individual po-
tential risk factors including carriage of other pathogens
(categorical variables). Distributions of continuous vari-
ables were compared between BHS carriers and non-
carriers using independent sample t-test (if approxi-
mately normal) or non-parametric Wilcoxon rank-sum
test (if non-normal).
Univariable (simple) and multivariable (multiple) logis-
tic regression analyses were then performed to estimate
unadjusted and adjusted odds ratios (respectively) with
their 95 % confidence intervals to quantify the associa-
tions of BHS carriage prevalence with the potential risk
factors. The confounding effects of other variables and
presence of statistical interactions were also assessed
during multiple logistic regression analyses. The com-
bination of risk factors mutually associated with BHS
was identified using a stepwise backward elimination
(logistic regression) procedure, with an exclusion p
value of 0.1.
Results
There were 1200 participants aged 2 months of which
1170 (97.5 %) had complete data for analysis. The algo-
rithm for recruitment and sample processing flow is
shown in Fig. 1. The characteristics of the study popula-
tion are summarized in Table 1.
Prevalence of bacterial species
Figure 2a shows carriage of BHS and 4 common respira-
tory pathogens in the nasopharynx; with S. pneumoniae
being the highest (729/1170, 62.3 %) and H. influenzae
being the least (368/1170, 31.5 %) in carriage respect-
ively. All the H. influenzae isolates recovered were sero-
typed to be non-Hib.
Of 234 out of 1170 (20.0 %) BHS isolated, GBS was
the most dominant (162/234, 69.2 %), and GCS the least
prevalent (12/234; 5.1 %) (Fig. 2b). Two isolates that
could not be assigned to any Lancefield group (BHS
non-typeable) were excluded from the overall prevalence
and risk factor analyses. Similar proportions of males
and females carried BHS in their nasopharynx (127/579
(21.9 %) and 107/591 (18.1 %) respectively).
Serotype distribution of GBS
Of the 162 GBS isolates that were recovered, 133
(≈82 %) were successfully revived for serotyping.
Nine different GBS serotypes were identified of which
the most prevalent were serotypes V (50/133, 37.6 %)
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and II (46/133, 34.6 %), which together constituted ap-
proximately 72 % of all the GBS serotypes identified.
The other GBS serotypes were Ia (10/133, 7.5 %), IV (8/
133, 6.0 %), Ib (7/133, 5.3 %), VII (5/133, 3.8 %), VIII (1/
133, 0.8 %), III (1/133, 0.8 %) and VI (1/133, 0.8 %)
(Table 2). Serotyping by PCR resolved all strains that
were non-typeable by latex agglutination, except for 2
isolates (2/133, 1.5 %). Two infants were colonized
with two different serotypes (V & VII, and V & VIII
respectively).
The PCR method was in agreement with the latex ag-
glutination method in the 15.0 % (20 isolates) that were
confirmed by PCR.
Risk factors for BHS carriage
In univariate and multivariable logistic regression ana-
lyses of risk factors for BHS carriage, carriage of the
Streptococcus groups A-G was not associated with
gender, ethnicity, home or hospital delivery, or num-
ber of other siblings <5 years sleeping in the same
room as the participating infant. There were no sig-
nificant associations between the carriage of GAS or
GCS and a history of acute respiratory infection. In
contrast, a history of acute respiratory infection was
Fig. 1 Algorithm for recruitment and sample processing flow. + 1200 infants aged 2 months of consenting mothers were recruited for the study;
however 1170 (97.5 %) had complete data for analysis. † 162 GBS isolates were recovered in the study, however 133 (82 %) were successfully
revived for serotyping. * 21 GBS isolates were non-typeable (NT) by the latex agglutination method and were subjected to the conventional
Polymerase Chain Reaction serotyping method. In addition, 20 isolates typed by the latex agglutination method (15 %) were confirmed by PCR
Table 1 Demographic characteristic of 1170 Gambian 2-month
old infants participants
Characteristic n (%) %
Sex
Male 579 49.5
Female 591 50.5
Place of birth
Otherb 98 8.4
Health Facility 1072 91.6
Sleep Rma
0 374 32.4
1 433 37.5
2 214 18.5
3b 134 11.6
History of previous antibiotic use
No 1170 100
Yes 0 0
History of ARI
No 1041 89.0
Yes 129 11.0
ARI acute respiratory infection; aNumber of other siblings <5 years sleeping in
the same room with subject (data available for 1155 infants); bOther, At home/
delivered by a traditional birth attendant
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significantly associated with carriage of GGS (OR 2.42,
[95 % CI: 1.12–5.23], p = 0.025).
As shown in Table 3, GBS carriage was negatively as-
sociated with a history of acute respiratory infection (OR
0.28, [95 % CI: 0.13–0.63], p = 0.002).
Co-carriage of GBS and other pathogens
GBS was not carried along with any other BHS in
our study population. GBS co-colonization was most
frequent with S. aureus (104/583, 17.8 %), followed by
H. influenzae (38/368, 10.3 %), then S. pneumoniae
A
B
Fig. 2 a Nasopharyngeal carriage of respiratory pathogens in 2-month old Gambian infants. b Nasopharyngeal carriage of Beta-haemolytic
Streptococci In 2-month old Gambian infants. BHS – Beta-haemolytic Streptococci; GBS – Group B Streptococci; GGS – Group G; Streptococci;
GAS – Group A Streptococci; GCS – Group C Streptococci
Table 2 Temporal changes in the Group B Streptococcus Serotype distribution from the same geographic region (Fajikunda) in The
Gambia: 20 years apart
Study Year Description Total number
of isolates
% with serotype
Ia II III IV V VI VII VIII NT
Ref 24 May 1992 to February 1993 Maternal and infant colonization 32a 19 28 6 3 38 - - b - b 6
Present study July 2011 and May 2012 Infant colonization 133 7.5 34.6 0.8 6.0 37.6 0.8 3.8 0.8 1.5
aLancefield grouping was performed for only serotypes I-VI and did not include serotypes VI-IX
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(74/729, 10.2 %), and M. catarrhalis (36/375, 9.6 %)
(Table 3).
Association between BHS and four common respiratory
pathogens
As shown in Table 3, carriage of GBS was negatively as-
sociated with that of S. pneumoniae and M. catarrhalis
but positively associated with carriage of S. aureus (OR
1.89 [95 % CI: 1.33–2.69], p < 0.001). Although carriage
of GBS was also negatively associated with that of H.
influenzae in the univariate analysis this association was
not confirmed in multivariable analysis. We also found a
significant negative association between GBS serotype V
and the carriage of H. influenzae (OR 0.41 [95 % CI:
0.18 –0.93], p = 0.033).
Antibiotic susceptibility of GBS
All the GBS isolates tested were susceptible to Penicillin
and 97.0 % (129/133) were susceptible to Chlorampheni-
col. Resistance was highest to Tetracycline (119/133,
89.5 %) with a minority of isolates resistant to Erythro-
mycin (1/133, 0.8 %).
Discussion
To our knowledge, this is the first report of co-carriage
of GBS with other respiratory pathogens in the naso-
pharynx of two-month old infants. These data also pro-
vide an update on the circulating serotypes of GBS, as
available data from West Africa are from the 1990’s [24].
Additionally, we describe for the first time, the nasopha-
ryngeal prevalence of other GBS and BHS beyond neo-
natal period from West Africa.
We found a prevalence of GBS in the nasopharynx
14.0 % (162/1170), with an overall prevalence of BHS of
20.0 % (234/1170) in NPS examined (Fig. 2a and b).
Although data on nasopharyngeal carriage of GBS dur-
ing early infancy is sparse in West Africa, our findings
are consistent with an earlier study in the Gambia [24],
albeit in infants less than 24 h old, and from different
body sites.
Table 3 Risk factors for carriage of Group B Streptococcus
Risk factor Category N Positivity of outcome Univariable analysis Multivariable analysis
n (%) OR (95 % CI) p value OR (95 % CI) p value
Sex Male 579 90 (15.54) 1 1
Female 591 72 (12.18) 0.75 (0.54;1.05) 0.097 0.73 (0.52;1.04) 0.08
Place of Birth Other 98 9 (9.18) 1
H/F 1072 153 (14.27) 1.65 (0.81;3.34) 0.167 - -
Tribe Mandika 463 62 (13.39) 1
Wolof 164 22 (13.41) 1 (0.59;1.69) 0.994 - -
Fula 144 19 (13.19) 0.98 (0.57;1.71) 0.952 - -
Jola 215 24 (11.16) 0.81 (0.49;1.34) 0.418 - -
Others 184 35 (19.02) 1.52 (0.96;2.39) 0.072 - -
*sleep Room 0 374 59 (15.78) 1
1 433 58 (13.39) 0.83 (0.56;1.22) 0.339 - -
2 214 28 (13.08) 0.8 (0.49;1.31) 0.377 - -
3+ 134 14 (10.45) 0.62 (0.34;1.16) 0.134 - -
History of ARI 0 1041 155 (14.89) 1 1
1 129 7 (5.43) 0.33 (0.15;0.72) 0.005 0.28 (0.13;0.63) 0.002
S. pneumoniae Negative 441 88 (19.95) 1 1
Positive 729 74 (10.15) 0.45 (0.32;0.63) <0.001 0.47 (0.33;0.67) <0.001
H. influenzae Negative 802 124 (15.46) 1
Positive 368 38 (10.33) 0.63 (0.43;0.93) 0.019 - -
S. aureus Negative 587 58 (9.88) 1 1
Positive 583 104 (17.84) 1.98 (1.4;2.79) <0.001 1.89 (1.33;2.69) <0.001
M. catarrhalis Negative 795 126 (15.85) 1 1
Positive 375 36 (9.6) 0.56 (0.38;0.84) 0.004 0.61 (0.40;0.92) 0.017
H/F health facility, ARI acute respiratory infection; *Number of other siblings <5 years sleeping in the same room with subject. (−) indicates variables which were
not included in the multivariate analysis
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The 13-valent pneumococcal conjugate vaccine (PCV-
13) has been in use in The Gambia since April 2011, be-
fore the start of this study. Few studies have reported
changes in the epidemiology of bacterial carriage and
diseases associated with widespread use of the pneumo-
coccal conjugate vaccine [25, 26]. However, the preva-
lence of GBS carriage and disease in the post-PCV era
has not been properly described. New pneumococcal
vaccines capable of inducing non-serotype dependent
and broadly reacting immunity have been developed and
are in early clinical trials [27]. Introduction of these new
vaccines with the potential to disrupt nasopharyngeal
ecology may be associated with the potential risk of spe-
cies replacement including a more prominent role for
related organisms such as S. aureus.
We previously showed that S. pneumoniae was posi-
tively associated with both H. influenzae and M. catar-
rhalis, and negatively associated with S. aureus in NP
carriage [18]. In this study, we report for the first time,
an interesting interplay of associations between GBS and
other commonly studied respiratory pathogens. The
negative association we found between GBS and S. pneu-
moniae and the positive association with S. aureus sug-
gest that GBS may occupy a niche that overlaps with
that of S. pneumoniae and S. aureus. It is interesting to
note that the niche overlap between these pathogens
may actually be quite large amongst infants from this
setting as S. pneumoniae and S. aureus have both also
been isolated from the oropharynx where GBS typically
resides [18]. With respect to S. pneumoniae, the co-
existence appears to be antagonistic, whereas the con-
verse is true for S. aureus. Furthermore, no GBS isolate
was co-carried with another BHS. This is an interesting
finding and may suggest an exclusive pattern of co-
colonization amongst BHS of different Lancefield
groups, probably due to their metabolic similarities.
With the development of pneumococcal protein vac-
cines that may wipe out carriage of S. pneumoniae,
there’s a potential risk of increase in GBS carriage
with possible clinical consequences.
Although data on carriage of non-BHS in infants be-
longing to this age group is sparse, our findings are con-
sistent with the existing reports from other parts of the
world [28, 29]. In a cross-sectional study such as ours, it
is possible to have missed any BHS which may have a
seasonal pattern of colonization, such as have been
shown with S. pneumonia serotypes, 1 and 5 [30]. Con-
firming this would require studying a larger cohort of in-
fants in future studies to investigate BHS carriage
longitudinally.
In this study, the predominant GBS serotypes were V
(37.6 %) similar to what was found in an earlier study in
The Gambia, and II (34.6 %). In contrast to our findings,
this other study conducted two decades ago did not find
appreciable numbers of serotype II [24]. This suggests
the existence of temporal changes in the carriage of GBS
and most likely other BHS serotypes. The prevalence
also varies geographically. Globally serotype III plays a
major role in both early-onset and late-onset disease as
well as carriage in developing and developed countries
[31, 32]. However, this serotype comprised <1 % of GBS
isolates in our study. There is no GBS vaccine available
currently, although some vaccine candidates have been
tested in preclinical studies [33]. A Novartis glycoconju-
gate vaccine containing serotypes Ia, Ib and III is cur-
rently undergoing phase II trial [34]. Although the
carriage of GBS has not been shown to predispose to inva-
sive disease unlike in organisms such as S. pneumoniae, it
may be worthwhile for future vaccine development target-
ing developing countries such as The Gambia to consider
the geographical differences in serotype distribution.
Latex agglutination is the conventional method for
serotyping. Our data demonstrates the added utility of
PCR serotyping as it resolved majority of the serotypes
(19 of 21) identified as non-typeable by latex agglutin-
ation. The usefulness of such molecular serotyping tech-
niques has been reported in the literature [35].
Penicillin is the recommended first-line of treatment
for streptococcal infections, including GBS infections
and all GBS isolates in this study were found to be Peni-
cillin susceptible. Similar to other regions, we observed a
high rate of tetracycline resistance [36]; however this
antibiotic is not commonly used in children. Macrolides
are the recommended second line treatment option.
Globally, there is growing evidence of emerging resist-
ance of GBS to erythromycin [37, 38], making it import-
ant to probe resistance patterns to this antibiotic. In our
study, <1 % of GBS isolates were resistant to erythro-
mycin; with approximately 11 % showing intermediate
susceptibility; an indication that macrolide antimicrobial
resistance is not a major concern in our setting at this
time. Our findings are similar to reports from Brazil
where 4.7 % of colonizing GBS isolates were resistant to
erythromycin [39]; and Australia where 6.4 % of GBS
isolates were resistant to erythromycin [40].
Host specific factors such as age, race, breastfeeding,
attendance at day care amongst others have been shown
to affect colonization of S. pneumoniae, S. aureus, M.
catarrhalis, and H. influenzae [41]. Intercurrent or past
episodes of respiratory tract infections are also known to
increase colonization by these pathogens [41].
Contrary to results from other studies, multiple logis-
tic regression analyses in this study did not yield any as-
sociation between GBS carriage and gender, ethnic
group and overcrowding. In addition, GBS carriage was
inversely associated with a history of acute respiratory
infection. This finding is interesting, as it suggests that
recent acute respiratory infection may have an impact
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on GBS carriage. However, we note that none of the
study participants had any history of previous antibiotic
use. Thus it may likely be a chance finding (although
statistically significant).
Conclusions
In light of our findings, and evidence from elsewhere [25,
26], we recommend that invasive bacterial disease surveil-
lance following introduction of new vaccines should in-
clude monitoring not just for serotype replacement but
also species replacement in carriage and invasive pneumo-
coccal disease. In addition, close surveillance monitoring
is required to detect the emergence of bacterial antimicro-
bial resistance in the Gambia. We have shown that GBS
has negative and positive associations with S. pneumoniae
and S. aureus respectively. We have also shown that the
GBS serotype V remains dominant in colonization of
Gambian infants, and is negatively associated with the car-
riage of H. influenzae. We have also found an emergence
of GBS serotype II. Although preliminary, this information
is important information for future vaccine development
for West African countries.
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